Search hospitals
>
Ontario
>
TORONTO
University Health Network
Claim this profile
TORONTO, Ontario M5G 2C4
Global Leader in Prostate Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Depression
Conducts research for Breast Cancer
541 reported clinical trials
60 medical researchers
Summary
University Health Network is a medical facility located in TORONTO, Ontario. This center is recognized for care of Prostate Cancer, Cancer, Lung Cancer, Depression, Breast Cancer and other specialties. University Health Network is involved with conducting 541 clinical trials across 709 conditions. There are 60 research doctors associated with this hospital, such as Lillian Siu, MD, Marcus Butler, Anna Spreafico, MD PhD, and Peter Chung, MD.
Area of expertise
Prostate Cancer
University Health Network has run 33 trials for Prostate Cancer. Some of their research focus areas include:
Cancer
University Health Network has run 29 trials for Cancer. Some of their research focus areas include:
Top PIs
Lillian Siu, MD
Princess Margaret Cancer Centre
7 years of reported clinical research
Marcus Butler
Princess Margaret Cancer Centre
9 years of reported clinical research
Anna Spreafico, MD PhD
Princess Margaret Cancer Centre
7 years of reported clinical research
Peter Chung, MD
University Health Network, Princess Margaret Hospital
2 years of reported clinical research
Clinical Trials running at University Health Network
Breast Cancer
Cancer
Prostate Cancer
Bladder Cancer
Brain Tumor
Melanoma
Multiple Myeloma
Thalassemia
Pancreatic Cancer
Colorectal Cancer
Sentinel Lymph Node Biopsy
for Breast Cancer
This is a prospective, open-label, within-patient clinical trial to determine the accuracy of Indocyanine green (ICG) guided sentinel lymph node biopsy (SLNB) compared to the standard dual-tracer SLNB in breast cancer patients who have had chemotherapy as a first treatment using a non-inferiority design. Patients with operable breast cancer treated with chemotherapy and eligible for SLNB will be included in the study. During surgery, ICG will be injected and used to identify fluorescent sentinel nodes using a hand-held imaging camera; radiotracer and blue dye will also be used as per standard protocols. Intraoperative and clinicopathologic outcomes such as complications, characteristics of nodes, false negative rates and feasibility will be assessed. Patients will be asked to complete standardized patient reported outcome questionnaires (Breast-Q, FACT-B+4, VAS) to define the patient experience with this novel technique.
Recruiting
1 award
N/A
6 criteria
Anakinra
for Breast Cancer
This study will examine changes in the tumor microenvironment (TME) induced by 14 days of pre-operative IL-1-inhibiting therapy among patients with early breast cancer (including TNBC and ER-low positive). Key immune biomarkers (TILs, TAMs, NK cells, IL1\[beta\] and inflammasome component expression) will be evaluated at baseline and following 14 days of IL-1 antagonist therapy (Anakinra) using paired tissue specimens.
Recruiting
1 award
Phase 2
3 criteria
PEM vs Liquid Biopsy
for Breast Cancer
The goal of this research study is to evaluate the performance of two experimental tests, namely Liquid Biopsy and Positron Emission Mammography (PEM) in women at high risk of breast cancer. The plan for this study is to assess whether findings from the combination or each individual test can assist radiologists in visualizing and characterizing beast abnormalities. Liquid Biopsy is a blood test that can detect early tumours in patients with malignancies, while PEM is an imaging tool equipped with a high-resolution camera that uses a low dose of injected positron emitting isotope to locate breast tumours. Participation in this study entails a blood draw for Liquid Biopsy test and a PEM imaging exam before undergoing a magnetic resonance imaging (MRI) - guided biopsy for a suspicious breast lesion. If PEM and/or Liquid Biopsy provide accurate information to assist radiologists in visualizing and characterizing breast abnormalities, this method may serve as the first step towards establishing these genomic and new imaging technologies as new diagnostic modalities and ultimately reduce the unnecessary biopsies and anxiety in high-risk populations.
Recruiting
1 award
N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University Health Network?
University Health Network is a medical facility located in TORONTO, Ontario. This center is recognized for care of Prostate Cancer, Cancer, Lung Cancer, Depression, Breast Cancer and other specialties. University Health Network is involved with conducting 541 clinical trials across 709 conditions. There are 60 research doctors associated with this hospital, such as Lillian Siu, MD, Marcus Butler, Anna Spreafico, MD PhD, and Peter Chung, MD.
Where is University Health Network located?
**University Health Network Hospital Location and Access:** - **Address:** 200 Elizabeth St, Downtown Toronto, ON. Located near the intersection of College Street and University Avenue. - **Public Transportation:** Accessible via Queen's Park subway station on Line 1 (Yonge-University-Spadina line), 506 Carlton, and 505 Dundas streetcars. - **Parking:** Available at the hospital. Note: Street parking is restricted.
Who should I call to ask about financial aid or insurance network?
For financial assistance at University Health Network: - Contact by phone: 888.531.3004 (Monday-Friday, 8am - 4:30pm) or use the online form. - For insurance inquiries: Call 210-358-3350 or use the Contact Us form. Verify insurance acceptance with your provider. - Billing support: Call 210-358-3260. - Apply for financial assistance through the University Health Financial Assistance Program, considering residency, income, and family size.
What insurance does University Health Network accept?
The University Health Network (UHN) accepts a wide range of insurance plans, including Medicare, Medicaid/Health First CO, and many others, and strives to be in-network for most insurance plans. However, patients are advised to confirm network status and coverage details with their insurance provider and clinic before receiving services. Similarly, CU Medicine and University Hospitals Lake West Medical Center accept most major insurance plans, but it is crucial for patients to verify specific provider participation and in-network status with their insurance carrier prior to their visit to avoid unexpected out-of-pocket expenses.
What awards or recognition has University Health Network received?
University Health Network (UHN) in Toronto, Ontario, Canada, specializes in health research and patient care across various domains including cancer, cardiovascular sciences, and transplantation. Affiliated with the University of Toronto, UHN is a key player in the Toronto Academic Health Science Network, emphasizing innovation in medical research and education. Its renowned research institutes, such as the Krembil Research Institute and the Princess Margaret Cancer Centre, are internationally recognized for their medical contributions.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.